Alliances
BioIVT will help to generate drug discovery target validation data and characterize novel therapeutics
Todos Medical Ltd. and Orot+ announced the enrollment of the first patient in the pre-commercial launch study of TM-B1 and TM-B2 in Europe.
Silence Therapeutics, PLC announces the triggering of the first $2 million in research milestones for SLN500 under the collaboration with Mallinckrodt Pharmaceuticals, a global biopharmaceutical company.
Firma Clinical Research, a niche service provider, is partnering with The Myositis Association on a multi-faceted project to better integrate the experience of patients into the training of clinical trial investigators and support providers.
Germany-based Evotec is partnering with Japan’s Takeda Pharmaceutical to develop at least five drug discovery programs across a broad range of indications.
Fujitsu and PeptiDream Leverage Quantum-Inspired Tech in Joint Research to Accelerate Drug Discovery
Fujitsu’s Quantum-Inspired Digital Annealer technology applied to drug discovery process to streamline the search for candidate compounds
APEX Biologix, a nationally recognized leader in manufacturing and distributing cutting-edge biologic supplies will now have access to an exciting new product.
Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris
The Case-Coulter Translational Research Partnership (CCTRP) between Case Western Reserve University and the Wallace H. Coulter Foundation has announced more than $1.1 million in 2019 funding and support for seven biomedical technologies.
Helsinn and Recordati Rare Diseases announce that a co-sponsored Symposium, organized by the two companies at the European Society for Dermatological Research Annual Meeting, , will provide a better knowledge of Chlormethine Gel’s mode of action as well as guidance on the management of the Chlormethine gel induced dermatitis.
PRESS RELEASES